T, H., T, K., K, K., K, O., K, O., Y, A., . . . A, O. (2026). Relationship between immune-related adverse events and treatment outcome of immune checkpoint inhibitors for advanced non-small cell lung cancer: A retrospective cohort study. Journal of thoracic disease, 18(2), 89. https://doi.org/10.21037/jtd-2025-1434
Chicago Style (17th ed.) CitationT, Hashimoto, et al. "Relationship Between Immune-related Adverse Events and Treatment Outcome of Immune Checkpoint Inhibitors for Advanced Non-small Cell Lung Cancer: A Retrospective Cohort Study." Journal of Thoracic Disease 18, no. 2 (2026): 89. https://doi.org/10.21037/jtd-2025-1434.
MLA (9th ed.) CitationT, Hashimoto, et al. "Relationship Between Immune-related Adverse Events and Treatment Outcome of Immune Checkpoint Inhibitors for Advanced Non-small Cell Lung Cancer: A Retrospective Cohort Study." Journal of Thoracic Disease, vol. 18, no. 2, 2026, p. 89, https://doi.org/10.21037/jtd-2025-1434.
